City
Epaper

New study shows how malaria parasite damages brain

By IANS | Updated: September 19, 2025 16:00 IST

New Delhi, Sep 19 Researchers have identified how the malaria parasite Plasmodium falciparum affects the brain, an advance ...

Open in App

New Delhi, Sep 19 Researchers have identified how the malaria parasite Plasmodium falciparum affects the brain, an advance that may help develop potential therapeutics that could help prevent or even reverse the damage.

Cerebral malaria kills one out of five children who suffer from it and also causes long-term disabilities in half of the survivors.

Malaria is caused by the parasite Plasmodium falciparum, which reproduces in our red blood cells and then breaks out of them to continue infecting new cells.

Once the parasite makes it to the blood-brain barrier (BBB) -- a structure that protects the brain from harmful substances -- it can damage it, causing severe complications.

To understand its effects, researchers from the European Molecular Biology Laboratory (EMBL) in Barcelona, Spain, created a lab-grown BBB to show how the parasite damages it.

"You have to imagine the BBB as a system of tightly sealed pipes that prevent leaks. The malaria parasite is capable of developing cracks in those pipes and creating a leak that starts dripping infected fluid into the brain, causing swelling and making the disease irreversible," said Livia Piatti, postdoctoral student at EMBL.

The lab-grown infection model of the human BBB included the key cellular players: endothelial cells that line the blood vessels, supporting pericytes, and astrocytes, which are star-shaped brain cells, all arranged in a 3D structure with flowing fluid.

The miniature BBB-on-a-chip (3D-BBB) was exposed to the parasite at its most explosive stage: the moment it bursts out of red blood cells in a process called egress.

The findings, published in the journal Nature Communications, indicated that the barrier had become more permeable.

In addition, analysis of gene expression at the single-cell level showed that cells were producing less of the proteins that keep the BBB sealed, and more of the molecules that cause inflammation.

Further, the researchers successfully tested an approved drug, Ruxolitinib, on their 3D-BBB model, with results suggesting that it could be effective for deadly cases of malaria.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalEAM Jaishankar meets FMs of South Africa, Mexico, Saskatchewan Premier on sidelines of G7 Foreign Ministers' Meet

NationalECI's decision to relax BLA appointment norms irks Trinamool, BJP welcomes move

Cricket"Great X-factor that they possess": England skipper hails Archer and Wood's pace ahead of Ashes 2025

BusinessIIM Udaipur Hosts 'Startup Showcase & Pitch Day' Organized by IIM Udaipur Incubation Centre and Saksham - The Entrepreneurship Cell

TechnologyMoney supply rises for 6th straight month amid strong stock market: BOK

Health Realted Stories

HealthRajasthan: Use of ABHA ID in IHMS made mandatory; health records to be available on mobile

HealthKerala govt medical colleges teachers body to continue stir, cites Finance Department's 'apathy'

HealthIndia extends Rs 4,000 crore line of credit to Bhutan, grants land in Varanasi for Bhutanese temple

HealthKerala HC directs statewide search to trace missing man brought from Kuwait

HealthIndia on the cusp of massive opportunity in medical tourism sector: Minister